United Kingdom Radiopharmaceuticals

Europe Nuclear Medicine Market, By Type (Diagnostic (SPECT, PET)), Therapeutic (Beta Emitters, Alpha Emitters))); By Application (Diagnostic (SPECT, PET)), Therapeutic (Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others)); By Procedural Volumes (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals)), Therapeutic (Beta Emitters, Alpha Emitters, Brachytherapy)); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

Dec 07, 2023  |  Published by: BlueWeave Consulting  |  USD 3,599

... By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Europe Nuclear Medicine Market Size almost Doubles at Robust CAGR of 12.03% during 2023–2029, ... Read More